Nasdaq cleared Canary Capital's staked Injective ETF for listing, with shares set to trade as INJC once registration turns effective.
According to an SEC Form 8-A12B dated November 3, 2026, The Nasdaq Stock Market approved listing of Canary Capital Group's Canary Staked INJ ETF. The fund seeks INJ price exposure while staking at least 90% of holdings under normal conditions through the sponsor's staking program, names BitGo as custodian, and lists a 1.10% annual sponsor fee. Trading still waits on the S-1 registration becoming effective — a listing approval is not the same as a launch day.
CoinDesk reported on November 5 that $INJ led the CoinDesk 100 after the news, up about 6% since midnight UTC and roughly 10% over 24 hours. The next checkpoints are effectiveness and the first INJC session on Nasdaq.
#Injective #ETF #Crypto
DYOR. Not financial advice.
According to an SEC Form 8-A12B dated November 3, 2026, The Nasdaq Stock Market approved listing of Canary Capital Group's Canary Staked INJ ETF. The fund seeks INJ price exposure while staking at least 90% of holdings under normal conditions through the sponsor's staking program, names BitGo as custodian, and lists a 1.10% annual sponsor fee. Trading still waits on the S-1 registration becoming effective — a listing approval is not the same as a launch day.
CoinDesk reported on November 5 that $INJ led the CoinDesk 100 after the news, up about 6% since midnight UTC and roughly 10% over 24 hours. The next checkpoints are effectiveness and the first INJC session on Nasdaq.
#Injective #ETF #Crypto
DYOR. Not financial advice.
